ECILC Stock Overview
Together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺44.08 |
| 52 Week High | ₺64.80 |
| 52 Week Low | ₺37.20 |
| Beta | 0.061 |
| 1 Month Change | -4.22% |
| 3 Month Change | -4.75% |
| 1 Year Change | -11.06% |
| 3 Year Change | 323.85% |
| 5 Year Change | 845.92% |
| Change since IPO | 950,719.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| ECILC | TR Personal Products | TR Market | |
|---|---|---|---|
| 7D | -1.8% | 1.0% | 0.04% |
| 1Y | -11.1% | -2.2% | -3.7% |
Return vs Industry: ECILC underperformed the TR Personal Products industry which returned -1.8% over the past year.
Return vs Market: ECILC underperformed the TR Market which returned -5.2% over the past year.
Price Volatility
| ECILC volatility | |
|---|---|
| ECILC Average Weekly Movement | 5.3% |
| Personal Products Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in TR Market | 9.7% |
| 10% least volatile stocks in TR Market | 5.2% |
Stable Share Price: ECILC has not had significant price volatility in the past 3 months compared to the TR market.
Volatility Over Time: ECILC's weekly volatility (5%) has been stable over the past year.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 1,088 | Emin Fadillioglu | www.eis.com.tr |
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment produces and sells human health and veterinary medicines, as well as engages in pharmaceutical sales and marketing. Its Real Estate Development segment develops real estate properties; engages in leasing activities for serum facilities; and provides consulting services on land development and project management.
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Fundamentals Summary
| ECILC fundamental statistics | |
|---|---|
| Market cap | ₺30.21b |
| Earnings (TTM) | ₺1.02b |
| Revenue (TTM) | ₺8.77b |
29.5x
P/E Ratio3.4x
P/S RatioIs ECILC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ECILC income statement (TTM) | |
|---|---|
| Revenue | ₺8.77b |
| Cost of Revenue | ₺5.83b |
| Gross Profit | ₺2.94b |
| Other Expenses | ₺1.92b |
| Earnings | ₺1.02b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.49 |
| Gross Margin | 33.52% |
| Net Profit Margin | 11.68% |
| Debt/Equity Ratio | 6.9% |
How did ECILC perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yield28%
Payout RatioDoes ECILC pay a reliable dividends?
See ECILC dividend history and benchmarks| EIS Eczacibasi Ilaç Sinai ve Finansal Yatirimlar Sanayi ve Ticaret dividend dates | |
|---|---|
| Ex Dividend Date | May 14 2025 |
| Dividend Pay Date | May 16 2025 |
| Days until Ex dividend | 25 days |
| Days until Dividend pay date | 27 days |
Does ECILC pay a reliable dividends?
See ECILC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/17 13:31 |
| End of Day Share Price | 2025/04/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nergis Bayraktar | Burgan Securities |
| Özgür Uçur | QNB Invest |
| Özgür Göker | UniCredit Research |